Coumarins as novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer

Bioorganic & Medicinal Chemistry Letters(2010)

Cited 46|Views7
No score
Abstract
Compound 4p was identified as a potent selective inhibitor of 17β-HSD3 resulting in the discovery of a novel lead series for further optimization.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined